Molecular pathogenesis of heart failure and arrhythmia caused by gene abnormalities
Project/Area Number |
16H05296
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Cardiovascular medicine
|
Research Institution | Tokyo Medical and Dental University |
Principal Investigator |
KIMURA Akinori 東京医科歯科大学, 難治疾患研究所, 教授 (60161551)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2018: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2017: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2016: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
|
Keywords | 遺伝学 / 遺伝子 / ゲノム / 循環器・高血圧 / 生体分子 |
Outline of Final Research Achievements |
Targeted sequencing system for disease genes of hereditary cardiomyopathy and/or hereditary arrhythmia was developed. RBM20 mutations in dilated cardiomyopathy were demonstrated for functional alterations. A novel disease gene for hypertrophic cardiomyopathy was identified, which altered methylation status of several specific loci in genome DNA. Analysis of transgenic mice specifically expressing human M21 in the heart demonstrated that high expression of M21 lead to cardiomyocytes hypertrophy with myofibrillar disarrays and later development of systolic dysfunction resembling to dilated phase hypertrophic cardiomyopathy, while low expression of M21 did not. Gene expression study revealed that expression of cardiac remodeling genes were altered even in the hearts from mice with low expressing M21, while MAP kinase and TGFb pathways were specifically changed only in the hearts from mice with high expression of M21.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究では、遺伝性心筋症・遺伝性不整脈について、既知の原因遺伝子の変異を網羅的に検索するシステムを構築し、その有用性を示した。また、新たに見出した多数の病因変異の機能異常を解明した。とりわけ、RBM20変異による拡張型心筋症の病態形成機序やカルシウム感受性異常が肥大型心筋症の病態形成に至る機序を解明した。さらに、新規の原因遺伝子を複数同定した。これらの知見は、遺伝性心疾患の診断や病態解明に供するのみならず、一般の心不全・不整脈の病態解明ひいては治療法開発にも繋がる。
|
Report
(4 results)
Research Products
(19 results)
-
-
-
-
-
-
[Journal Article] Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization2018
Author(s)
Rie Murayama, Mariko Kimura-Asami, Marina Togo-Ohno, Yumiko Yamasaki-Kato, Taeko K. Naruse, Takeshi Yamamoto, Takeharu Hayashi, Tomohiko Ai, Katherine G. Spoonamore, Richard J. Kovacs, Matteo Vatta, Mai Iizuka, Masumi Saito, Shotaro Wani, Yuichi Hiraoka, Akinori Kimura & Hidehito Kuroyanagi
-
Journal Title
Scientific Reports
Volume: 印刷中
Issue: 1
Pages: 8970-8983
DOI
NAID
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
[Journal Article] ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage2017
Author(s)
Sato T, Sato C, Kadowaki A, Watanabe H, Ho L, Ishida J, Yamaguchi T, Kimura A, Fukamizu A, Penninger JM, Reversade B, Ito H, Imai Y, Kuba K
-
Journal Title
Cardiovasc Res
Volume: 113(7)
Issue: 7
Pages: 760-769
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
[Journal Article] Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and Zebra body2016
Author(s)
Oikawa M, Sakamoto N, Kobayashi A, Suzuki A, Yoshihisa A. Yamaki T, Nakazato K, Suzuki H, Saitoh S, Kiko Y, Nakano H, Hayashi T, Kimura A, Takeishi Y
-
Journal Title
BMC Cardiovasc Disord.
Volume: 16
Issue: 1
Pages: 83-83
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Hypertrophic Cardiomyopathy Accompanied by Spinocerebellar Atrophy With a Novel Mutation in Troponin I Gene2016
Author(s)
Kawai H, Morimoto S, Takakuwa Y, Ueda A, Inada K, Sarai M, Arimura T, Mutoh T, Kimura A, Ozaki Y
-
Journal Title
International Heart Journal
Volume: 57
Issue: 4
Pages: 507-510
DOI
NAID
ISSN
1349-2365, 1349-3299
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-